Correction: Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients (BMC Cardiovascular Disorders, (2025), 25, 1, (879), 10.1186/s12872-025-05316-0)
JavaScript is disabled for your browser. Some features of this site may not work without it.
Correction: Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients (BMC Cardiovascular Disorders, (2025), 25, 1, (879), 10.1186/s12872-025-05316-0)
Esteban-Fernández, Alberto; López-Fernández, Silvia; Pastor-Pérez, Francisco-José; Pérez-Rivera, José Ángel; Bonilla-Palomas, Juan Luis; Cobo-Marcos, Marta; García-Pinilla, José Manuel; Almenar-Bonet, Luis; Fluviá-Brugués, Paula; Bermúdez-Jiménez, Francisco J; Goena-Vives, Cristina; López-López, Andrea; Gómez-Otero, Inés